Diagnostic screening programs help catch cancer, abnormalities or other diseases before they reach an advanced stage, saving lives and healthcare costs. Screening programs include, lung, breast, prostate, and cervical cancer, among many others.
It is estimated that less than 20% of eligible patients in the U.S. adhere to LCS recommendations, despite numerous studies highlighting the exam’s effectiveness.
Chest X-rays could be the key to mitigating the issue of overdiagnosis in certain patient populations undergoing lung cancer screening, according to new research.
Reactive axillary lymph nodes seen on screening mammograms after vaccination can last for many months and should not be cause for imaging delays, experts reported in Radiology.
After surgical excision, 10.2% of the architectural distortion cases with nonmalignant pathology at biopsy were upgraded to malignant, researchers reported in the American Journal of Roentgenology.
After witnessing a 6-fold increase in early-stage cancer diagnoses and no change in late-stage disease numbers, experts began to question ongoing screening methods.